Consensus Cloud’s Guidance Rationale and VA Runway Claims Clash in Q2 2026 Earnings Call

Date of Call: Aug 6, 2026

Financials Results

• Revenue: $91.4M, up 4.1% YOY
• EPS: $1.49 per diluted share, up 2.1% YOY
• Operating Margin: 52.9% adjusted EBITDA margin, within target range of 50% to 55%

Guidance:

• Full year 2026 revenue expected between $350M and $364M.
• Full year 2026 adjusted EBITDA expected between $182M and $193M.
• Full year 2026 adjusted EPS expected between $5.55 and $5.95.
• Q3 2026 revenue expected between $89.2M and $93.2M.
• Q3 2026 adjusted EBITDA expected between $44.6M and $47.4M.
• Q3 2026 adjusted EPS expected between $1.39 and $1.44.
• Full year 2026 free cash flow expected to approximate $106M of 2025.

Business Commentary:

Revenue Growth and Corporate Segment Performance:

• ConsenSys reported consolidated revenue of $91.4 million for Q2 2026, up 4.1% year-over-year, marking the fifth consecutive quarter of year-over-year revenue growth.
• The corporate channel achieved a record $60.5 million in revenue, representing a 9.3% year-over-year increase and a 3% sequential increase from Q1.
• Growth was driven by increased revenue retention, new customer acquisition, and strong usage of advanced products, particularly in the healthcare sector.

Soho Channel Performance and Strategy:

• The Soho channel revenue was $30.9 million, decreasing by 4.7% year-over-year, a slowing decline from the 9.5% decrease in Q1 2026.
• The company is managing the Soho channel as a cash engine, prioritizing cash optimization and contribution margin over absolute subscriber volume.
• This strategy aims to fuel the growth of the more profitable corporate segment.

Healthcare Strategy and DocHealth Acquisition:

• ConsenSys announced the formation of a new healthcare strategy and solutions group and the acquisition of DocHealth, a workflow platform for clinical adjacent work.
• The acquisition adds 14 employees, a customer base, and technology, aligning with the company's vision to expand non-fax revenue and enhance workflow solutions in healthcare.
• The move is part of a broader strategy to target specific segments and use cases in the healthcare system, aiming for meaningful contributions to non-fax revenue by 2028.

Public Sector and VA Engagement:

• The Department of Veterans Affairs (VA) mandated eFax as the secure fax solution, contributing to a highly qualified lead pipeline in the public sector.
• This policy is expected to drive a VA revenue contribution of north of $9 million in 2026, enhancing the company's credibility and opening doors for further public sector wins.
• The VA engagement is part of a broader strategy to expand in the public sector and leverage government contracts.

Financial Metrics and Guidance:

• Adjusted EBITDA for Q2 2026 was $48.3 million, with a margin of 52.9%, within the target range of 50% to 55%.
• Free cash flow was $25.5 million, up approximately 25% year-over-year due to improved receivables management and lower interest expenses.
• The company reaffirmed its full-year 2026 outlook, expecting revenue between $350 million and $364 million, with adjusted EBITDA and EPS ranges provided, incorporating the DocHealth acquisition.

Sentiment Analysis:

Overall Tone: Positive

• "We had excellent financial results in Q2, continuing our acceleration of total revenue growth... This was the third consecutive quarter that we had year-over-year revenue, adjusted EBITDA, adjusted non-GAAP EPS, and improvement in our corporate channel... We exceeded our revenue objective..." "Corporate revenue posting a 9.3% growth over Q2 2025 ahead of our forecast..." "Our record Q2... continues the corporate momentum..."

Q&A:

• Question from Jenny Shen (BTIG): Have your conversations with hospitals changed at all? and are the way that you're pitching your products changing?... And along the line, Beats, what was your decision to reaffirm observatism given the environment? Thanks. The full year guide without raising it, is that just added consistency?
  Response: Management acknowledged hospitals are slowing down, more diligent in vendor selection, and focused on EHR integration. They are emphasizing ROI in their pitches. The full-year guidance was reaffirmed due to a philosophy of consistency, with current performance expected to be above the midpoint but not sufficient to raise the range.

• Question from Isaac Saazen (Oppenheimer): On the VA EEC facts, the additional color you can provide on how many sites that includes, and you talked about the contribution for this year. Maybe I runway for growth going forward... And then, you know, induct our customers and potential conversations with the customers. In addition to that, maybe highlight your expectations around adoption from other public...
  Response: Management estimated VA rollout completion at 65-80%, with active conversations with government contractors. The VA mandate provides credibility and tailwinds, but other public sector wins are in early stages and may take years to close. VA contribution is expected to be north of $9M for 2026.

• Question from Isaac Saazen (Oppenheimer): Just on the EBITDA margin in the quarter, you know, I think you had previously talked about some hiring across the organization. You know, maybe you could just provide an update on where the company stands on that. And then, you know, I guess the guidance implies margins are towards the lower end of your guys' target for the back half. So, yeah, just any clarification as far as first hiring there.
  Response: Hiring has caught up to about 550 employees, up 32 from the start of the year, with growth in go-to-market and healthcare solutions. This will increase comp expense. Additionally, accounting fees in Q3 and Q4 will create seasonal margin pressure, but efforts are underway to spread these costs more evenly across quarters.

Contradiction Point 1

Guidance Philosophy and Driver for Reaffirmed Full-Year Guide

Contradictory explanations for not raising the full-year guidance.

Jenny Shen (BTIG) - Jenny Shen (BTIG)

2026Q2: The company's philosophy on guidance is to provide a range... However, neither beats nor the outlook are sufficient to change the full-year range. - [Scott Tariki](CFO)

"Given the current environment, why did you reaffirm conservatism, and is maintaining the full-year guidance without adjustments a reflection of added consistency?" - Jenny Shen (BTIG)

2026Q1: The guidance range was set a quarter ago... The reaffirmed range is considered sufficient. - [Scott Turicchi](CEO)

Contradiction Point 2

Timeline and Impact of Hiring on Margins

Contradictory statements on when and how hiring impacts margins.

Isaac Saazen (Oppenheimer) - Follow-up - Isaac Saazen (Oppenheimer) - Follow-up

2026Q2: Hiring has caught up, increasing employees from ~520 at year-start to ~550 by Q2. Cost growth is expected to continue in Q3/Q4. Margins in Q3/Q4 are seasonally lower... - [Scott Tariki](CFO)

Does the guidance imply that EBITDA margins for the quarter are towards the lower end of your target range for the back half of the year? - Jenny Shen (BTIG)

2026Q1: Hiring in go-to-market, product, and engineering will increase throughout the year, which will impact margins... This hiring dynamic is factored into the reforecast for the remainder of the year and the Q2 guidance. - [Scott Turicchi](CEO)

Contradiction Point 3

Hospital Demand Environment and Growth Outlook

Hospital demand has shifted from engaging to slowing down and more cautious.

Jenny Shen (BTIG) - Jenny Shen (BTIG)

2026Q2: Hospitals are slowing down, more diligent in vendor selection... - [Johnny Holtz](CEO)

Have your conversations with hospitals changed, and have the ways you pitch your products evolved, in light of their expressed volume challenges this quarter? - David Larsen (BTIG, LLC, Research Division)

2025Q4: Hospitals initially hesitated... but are now engaging more. They focus on OpEx and cash management, showing increasing interest in Consensus's services. - [R. Turicchi](CEO)

Contradiction Point 4

VA Deal Contribution and Runway

The VA deal's contribution and its impact on future growth are presented differently.

Isaac Saazen (Oppenheimer) - Isaac Saazen (Oppenheimer)

2026Q2: VA contribution for 2026 is expected to be north of $9 million. Larger public sector wins are in progress; the VA mandate provides credibility and tailwind, but other agency deals take time to close. - [Johnny Holtz](CEO)

Can you provide additional details on the number of sites included in the VA EEC, the contribution for this year, and the growth runway moving forward? - David Larsen (BTIG, LLC, Research Division)

2025Q4: The VA exceeded 2025 projections, contributing over $5 million, with expectations for around $9 million in 2026. Success in VA rollout, adoption growth, and remaining runway are positive indicators. Engagement extends to other government agencies... - [R. Turicchi](CEO)

Contradiction Point 5

VA Revenue Growth Potential and Timeline

Contradiction on the timeline and certainty of reaching higher VA revenue milestones.

Isaac Saazen (Oppenheimer) - Isaac Saazen (Oppenheimer)

2026Q2: The VA site count is not publicly disclosed, but rollout is estimated at 65-80% complete. ... VA contribution for 2026 is expected to be north of $9 million. - [Johnny Holtz](CRO)

Can you provide additional color on the VA EEC's site count, this year's contribution, growth runway, customer adoption progress, and expectations for expansion into other public sectors? - David Larsen (BTIG)

20251106-2025 Q3: The long-term potential is multiples of that figure, likely between $10M and $20M+, but timing depends on VA rollout pace and contract expiration schedules. ... It may take at least 3 years or more to capture all traffic. - [James Malone](CFO)